Report overview
Rosacea is a common skin condition characterized by redness and visible blood vessels on the face. The nose and cheeks are the most affected regions. The signs and symptoms of Rosacea are small, red, pus-filled bumps which may flare up periodically. About half the patients experience eye dryness, irritation and swollen, reddened eyelids. Other symptoms include enlarged nose, thickening the skin on the nose, (rhinophyma). Rosacea predominantly affects middle-aged women having fair skin.
This report contains market size and forecasts of Rosacea Drugs in global, including the following market information:
Global Rosacea Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Rosacea Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Rosacea Drugs companies in 2021 (%)
The global Rosacea Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Topical Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rosacea Drugs include Nestle Skin Health, Teva, Mylan, Bayer, Sun Pharma, Perrigo, Bausch Health, GSK and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Rosacea Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rosacea Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rosacea Drugs Market Segment Percentages, by Type, 2021 (%)
Topical
Orals
Global Rosacea Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rosacea Drugs Market Segment Percentages, by Application, 2021 (%)
Drugs Stores
Hospital
Other
Global Rosacea Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rosacea Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rosacea Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Rosacea Drugs revenues share in global market, 2021 (%)
Key companies Rosacea Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Rosacea Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nestle Skin Health
Teva
Mylan
Bayer
Sun Pharma
Perrigo
Bausch Health
GSK
Pfizer
Allergan
Almirall
